Symbol="ITRM"
AssetType="Common Stock"
Name="Iterum Therapeutics PLC"
Description="Iterum Therapeutics plc, a clinical-stage pharmaceutical company, is engaged in the development of anti-infectives for multidrug resistant pathogens in Ireland and the United States. The company is headquartered in Dublin, Ireland."
CIK="1659323"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="BLOCK 2 FLOOR 3, HARCOURT CENTRE, HARCOURT STREET, DUBLIN, IE"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="12490100"
EBITDA="-32551000"
PERatio="None"
PEGRatio="None"
BookValue="0.547"
DividendPerShare="0"
DividendYield="0"
EPS="-4.47"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.336"
ReturnOnEquityTTM="-2.208"
RevenueTTM="0"
GrossProfitTTM="37000"
DilutedEPSTTM="-4.47"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="1"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1349.79"
PriceToBookRatio="0.445"
EVToRevenue="105.22"
EVToEBITDA="0.534"
Beta="1.588"
num_52WeekHigh="2.95"
num_52WeekLow="0.601"
num_50DayMovingAverage="1.072"
num_200DayMovingAverage="1.144"
SharesOutstanding="12980800"
DividendDate="None"
ExDividendDate="None"
symbol="ITRM"
open="0.94"
high="0.99"
low="0.93"
price="0.98"
volume="16093.00"
latest_trading_day="2023-08-21"
previous_close="0.96"
change="0.02"
change_percent="1.8499%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="68"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="32"
Volume_recent_avg="52946"
Change_recent_avg="0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="0.12"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="32"
Aroon_momentum_negative="68"
image_negative_thumbnail_id_1="1100"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0133.jpeg"
image_negative_thumbnail_id_2="1107"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0140.jpeg"
image_neutral_thumbnail_id_1="588"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_neutral_thumbnail_id_2="576"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_positive_thumbnail_id_1="990"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0152.jpeg"
image_positive_thumbnail_id_2="984"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0146.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
